Sentence examples for arm withdrawing from inspiring English sources

Reasons for premature withdrawal from treatment were also similar between the APV600/RTV and APV1200 arms, except for fewer patients in the APV600/RTV arm withdrawing due to protocol-defined virologic failure (1% vs 6%) (Table 1).

Patients treated with PPX received a median of two cycles of therapy vs three cycles in the docetaxel arm with more patients withdrawing from PPX for adverse events and more patients in the docetaxel arm withdrawing for progressive disease.

After she had done that, the arm withdrew, and then, for the first time, the child had peace beneath the earth.

One patient in each treatment arm withdrew from the study secondary to symptoms of depression.

No patients in either arm withdrew because of lack of treatment efficacy.

Nine of the 22 patients (41%) in the diet arm withdrew because of intolerance.

Additionally, 4% of patients in the PPX arm withdrew consent compared with 8% in the docetaxel arm (P=0.011).

A greater proportion of subjects in the HU arm withdrew prematurely due to adverse events (23% vs 4%), whereas a greater proportion in the non-HU arm withdrew due to protocol-defined virologic failure.

Five (7 %) and 2 (3 %) patients in the lapatinib plus vinorelbine arm withdrew due to investigator decision or protocol deviation, respectively.

One patient in the mFOLFIRI.3 arm withdrew consent after the first cycle of chemotherapy and was lost to follow-up.

Two patients in the capecitabine arm withdrew consent without study treatment and were excluded from the PP analysis.